**Question:** Ondansetron acts by inhibiting which of the following receptors?

A. Serotonin Receptor 5-HT3
B. Dopamine Receptor D2
C. Histamine Receptor H1
D. Cholinergic Receptor M3

**Core Concept:** Ondansetron is a medication used to prevent and treat nausea and vomiting. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

**Why the Correct Answer is Right:** Ondansetron works by specifically binding to and blocking the serotonin receptor 5-HT3. This receptor is primarily involved in the transmission of nausea and vomiting signals in the gastrointestinal tract. By inhibiting this receptor, ondansetron reduces the sensation of nausea and prevents vomiting.

**Why Each Wrong Option is Incorrect:**

A. Serotonin Receptor 5-HT3: As mentioned above, ondansetron targets and blocks this receptor, making option A incorrect.
B. Dopamine Receptor D2: Ondansetron does not target dopamine receptors, making option B incorrect.
C. Histamine Receptor H1: Ondansetron does not target histamine receptors, making option C incorrect.
D. Cholinergic Receptor M3: Ondansetron does not target cholinergic receptors, making option D incorrect.

**Clinical Pearl:** Ondansetron is a key component of multimodal antiemetic regimens used in cancer chemotherapy-induced nausea and vomiting prophylaxis and treatment. It targets the 5-HT3 receptor, which is mainly responsible for the emetic response to chemotherapy.

**Correct Answer:** A. Serotonin Receptor 5-HT3

---

The correct answer is A: Serotonin Receptor 5-HT3. Ondansetron is a selective serotonin receptor antagonist, meaning it specifically targets and blocks serotonin receptors. In this case, it targets the 5-HT3 receptor, which is involved in the transmission of nausea and vomiting signals in the gastrointestinal tract. By inhibiting this receptor, ondansetron effectively reduces the sensation of nausea and prevents vomiting.